Wall Street RegretsThe regret calculator.

What if you'd held ACXP?

A $1,000 investment in Acurx Pharmaceuticals, Inc. (ACXP) at the month-end close of 2021-06 would be worth $11.29 at the close of 2026-08 — -98.9% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $1,794.

$1,000 since 2021$11.29Total return-98.9%Multiple0.01×CAGR-58.0%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$11.29Gain+$-989 (-98.9%)Multiple0.0×CAGR-58.0%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2021$11.292022$16.662023$18.092024$18.802025$88.452026$578

    Every year, $1,000 from 2021

    YearValue of $1,000Year return
    2021$1,000
    2022$921-7.9%
    2023$886-3.8%
    2024$188-78.7%
    2025$28.81-84.7%
    2026$16.66-42.2%

    Best and worst month-end to buy

    The best single month-end close to have bought ACXP was 2026-07 ($1.42): $1,000 then is $1,014 today. The worst was 2021-06 ($128): $1,000 then is $11.29.

    FAQ

    What would $1,000 in ACXP be worth today?

    A $1,000 investment in Acurx Pharmaceuticals, Inc. (ACXP) at the start of 2021 would be worth about $11.29 today, a total return of -98.9%. Dividends are reinvested in these figures.

    What were the best and worst years for ACXP?

    Acurx Pharmaceuticals, Inc. (ACXP)'s strongest calendar year since 2021 was 2023, a -3.8% return — $1,000 held through that year became about $962 by year-end. Its weakest year was 2025, at -84.7%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in ACXP have grown?

    Investing $100 at the end of every month since 2021-06 would have grown to about $1,039 on $6,300 invested.

    Did ACXP beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $1,794. ACXP trailed the S&P 500 by +99.4% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Acurx Pharmaceuticals, Inc. (ACXP) historical total-return data from 2021-06 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.